Keith Stockerl-Goldstein

Professor of Medicine

Washington University in St. Louis

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Keith Stockerl-Goldstein is a Professor of Medicine at Washington University in St. Louis, USA. His research focuses on hematologic malignancies, particularly multiple myeloma and related treatments, as evidenced by his recent publications. Key areas of his work include measurable residual disease assessment, treatment outcomes in patients undergoing stem cell transplants, and the impact of financial toxicity in cancer care.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

View details

Elizabeth Nakasone

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Leah Gehrs

The University of Alabama

UNITED STATES

View details

Tahir Latif

University of Cincinnati Medical Center

UNITED STATES

View details

Michael Slade

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Denise Pereira

University of Miami

UNITED STATES

View details

Maheen Abidi

University of Colorado Boulder

UNITED STATES

View details

Michael Rettig

Washington University in St. Louis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Keith Stockerl-Goldstein

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

A Single Reference Interval for Interpreting Serum Free Light Chains across Patients with Varying Renal Function

Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study

The Dynamics of Financial Toxicity in Multiple Myeloma

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality

COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes.

A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy

Collaborators (12)

Feng Gao

Ramzi Abboud

Mark Fiala

Eric Huselton

John L. Frater

Elizabeth Nakasone

Leah Gehrs

Tahir Latif

Michael Slade

Denise Pereira

Maheen Abidi

Michael Rettig

Make your next move.